Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation

Radiotherapy and Oncology

Volumn 89, Issue 3, 2008, Pages 278-286

  Roedl, Johannes B ^a   Colen, Rivka R ^a   Holalkere, Nagaraj S ^a   Fischman, Alan J ^a   Choi, Noah C ^a   Blake, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemoradiotherapy; Esophageal cancer; PET CT; Response; Tumor volume

Indexed keywords

ANTIINFECTIVE AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 56949099284     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.06.014     Document Type: Article

References (33)

1. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
2. Gebski V., Burmeister B., Smithers B.M., et al. Survival benefits from neoadjuvant chemoradiatherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8 (2007) 226-234
3. Ancona E., Ruol A., Santi S., et al. Only pathologic complete response toneoadjuvant chemotherapy improves significantly the long-term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 91 (2001) 2165-2174
4. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335 (1996) 462-467
5. Berger A.C., Farma J., Scott W.J., et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23 (2005) 4330-4337
6. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
7. Swisher S.G., Maish M., Erasmus J.J., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78 (2004) 1152-1160
8. Ott K., Weber W.A., Lordick F., et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24 (2006) 4692-4698
9. Flamen P., Van Cutsem E., Lerut A., et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 13 (2002) 361-368
10. Song S.Y., Kim J.H., Ryu J.S., et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiation Oncology Biol Phys 63 (2005) 1053-1059
11. Arslan N., Miller T.R., Dehdashti F., et al. Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer. Mol Imaging Biol 4 (2002) 301-310
12. Siewert J.R., and Stein H.J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85 (1998) 1457-1459
13. Padhani A.R., and Ollivier L. The RECIST (Response evaluation criteria in solid tumors) criteria: implications for diagnostic radiologists. Br J Radiol 74 (2001) 983-986
14. WHO Handbook for Reporting Results of Cancer Treatment. Geneva: World Health Organization, Offset Publication No. 48, 1979.
15. Chak A., Canto M.I., Cooper G.S., et al. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 88 (2000) 1788-1795
16. Hong R., Halama J., Bova D., et al. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. Int J Radiat Oncol Biol Phys 67 (2007) 720-726
17. Leong T., Everitt C., Yuen K., et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 78 (2006) 254-261
18. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
19. Ciernik I.F., Huser M., Burger C., et al. Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 893-900
20. MacManus M., Hicks R., Bayne M., et al. In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radiat Oncol Biol Phys 60 (2004) 1005-1006
21. Scarfone C., Lavely W.C., Cmelak A.J., et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45 (2004) 543-552
22. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med 46 (2005) 1342-1348
23. Konski A., Doss M., Milestone B., et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1123-1128
24. Bruzzi F., Swisher S.G., Truong M.T., et al. Detection of interval distant metastases. Clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109 (2007) 125-134
25. Cerfolio R.J., Bryant A.S., Ohja B., et al. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129 (2005) 1232-1241
26. Larson S.M., Erdi Y., Akhurst T., et al. Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. Clin Positron Imaging 2 (1999) 159-171
27. Langer R., Specht K., Becker K., et al. Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis. Verh Dtsch Ges Pathol 88 (2004) 207-213
28. Therasse P., Le Cesne A., Van Glabbeke M., et al. RECIST vs WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. Eur J Cancer 41 (2005) 1426-1430
29. Werner-Wasik M., Xiao Y., Pequignot E., et al. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimentional product and volume. A serial CT scan-based study. Int J Rad Therapy Oncol Biol Phys 51 (2001) 56-61
30. Schwartz L.H., Colville J.A., Ginsberg M.S., et al. Measuring tumor response and shape change on CT: esophageal cancer as a paradigm. Ann Oncol 17 (2006) 1018-1023
31. Ng C.S., Husband J.E., MacVicar A.D., et al. Correlation of CT with histopathological findings in patients with gastric and gastrooesophageal carcinomas following neoadjuvant chemotherapy. Clin Radiol 53 (1998) 422-427
32. Beseth B.D., Bedford R., Isacoff W.H., et al. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 66 (2000) 827-831
33. Geets X., Lee J.A., Bol A., and Lonneux M. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 34 (2007) 1427-1438